Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.

Abstract

OBJECTIVE:

The iminosugar N-(5'-adamantane-1'-yl-methoxy)-pentyl-1-deoxynoijirimycin (AMP-DNM), an inhibitor of the enzyme glucosylceramide synthase catalyzing glycosphingolipid (GSL) biosynthesis, ameliorates diabetes and reduces liver steatosis in ob/ob mice. Because an accumulation of sphingolipids, including sphingomyelin and GSLs, has been reported in atherosclerotic lesions in animal models and in humans, the objective of this study was to determine whether AMP-DNM also exerts beneficial effects on the development of atherosclerosis.

METHODS AND RESULTS:

APOE*3 Leiden mice, maintained on a high-cholesterol diet, were treated for up to 18 weeks with AMP-DNM. The iminosugar prevented hyperlipidemia, generated a less atherogenic lipid profile, and induced a dramatic reduction in the development of atherosclerotic lesions. At the highest dose, no lesions were detectable. The effect of AMP-DNM was associated with a decrease in liver cholesterol, an increase in bile secretion, and enhanced excretion of cholesterol in the feces. Similar effects of AMP-DNM were observed in mice deficient for the low-density lipoprotein receptor.

CONCLUSION:

By lowering plasma cholesterol, the iminosugar AMP-DNM dramatically reduces the development of atherosclerosis in APOE*3 Leiden and low-density lipoprotein receptor -/- mice. Thus, targeting GSL synthesis may be a new treatment modality to prevent cardiovascular disease.

• Authors: Florence Bietrix, Elisa Lombardo, Cindy P A A van Roomen, Roelof Ottenhoff, Mariska Vos, Patrick C N Rensen, Arthur J Verhoeven, Johannes M Aerts, Albert K Groen
• Journal: Arteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 30 Issue 5 Pg. 931-7 (May 2010) ISSN: 1524-4636 [Electronic] United States
• PMID: 20167657 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Apolipoproteins E
• Enzyme Inhibitors
• Glycosphingolipids
• N-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin
• Receptors, LDL
• 1-Deoxynojirimycin
• Cholesterol
• Glucosyltransferases
• ceramide glucosyltransferase
• Adamantane

Topics

• 1-Deoxynojirimycin (analogs & derivatives, pharmacology)
• Adamantane (analogs & derivatives, pharmacology)
• Animals
• Apolipoproteins E (genetics)
• Atherosclerosis (genetics, metabolism, prevention & control)
• Bile (metabolism)
• Cholesterol (blood)
• Disease Models, Animal
• Dose-Response Relationship, Drug
• Down-Regulation
• Enzyme Inhibitors (pharmacology)
• Feces (chemistry)
• Female
• Glucosyltransferases (antagonists & inhibitors, metabolism)
• Glycosphingolipids (biosynthesis)
• Hyperlipidemias (genetics, metabolism, prevention & control)
• Kinetics
• Liver (drug effects, metabolism)
• Mice
• Mice, Inbred C57BL
• Mice, Knockout
• Mice, Transgenic
• Mutation
• Receptors, LDL (deficiency, genetics)